Urokinase Treatment of Deep Artery Thrombosis in Extremely Low Birth Weight Infant.
- Author:
Chang Guyn SHIN
1
;
Ji Won PARK
;
Jong Hee HWANG
Author Information
1. Department of Pediatrics, College of Medicine, Ilsan Paik Hospital, Inje University, Ilsan, Korea. jhhwang@paik.ac.kr
- Publication Type:Case Report
- Keywords:
Thrombosis;
Receptors;
Urokinase plasminogen activator;
Infant;
Extremely low birth weight
- MeSH:
Arteries;
Catheters;
Child;
Humans;
Infant;
Infant, Extremely Low Birth Weight;
Infant, Newborn;
Risk Factors;
Thromboembolism;
Thrombosis;
Urokinase-Type Plasminogen Activator;
Veins;
Venous Thrombosis
- From:Korean Journal of Perinatology
2010;21(4):418-423
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Newborns are at the highest risk for thromboembolism, although significant thromboembolic diseases are relatively rare in children and newborn. The use of central catheters seems to be the most important risk factor for vein and artery thrombosis. Additional risk factors include the properties of developing hemostatic system, hereditary, and acquired risk factors. Treatment for neonatal thromboembolism has not been established. We report a case of deep vein thrombosis that was completely treated with urokinse in extremely low birth weight infant.
